BANK OF AMERICA CORP /DE/ - NEUROSENSE THERAPEUTICS LTD ownership

NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NEUROSENSE THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$22
+37.5%
200
+100.0%
0.00%
Q2 2023$161000.00%
Other shareholders
NEUROSENSE THERAPEUTICS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Empery Asset Management, LP 160,000$82,0000.44%
Warberg Asset Management LLC 77,100$39,0000.01%
CLEAR STREET LLC 52,458$27,0000.00%
Hudson Bay Capital Management LP 150,000$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROSENSE THERAPEUTICS LTD shareholders